IGeneX Revenue and Competitors
Estimated Revenue & Valuation
- IGeneX's estimated annual revenue is currently $14.8M per year.
- IGeneX's estimated revenue per employee is $243,000
Employee Data
- IGeneX has 61 Employees.
- IGeneX grew their employee count by 15% last year.
IGeneX's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Marketing | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
3 | Senior Account Receivables Biller | Reveal Email/Phone |
4 | Clinical Laboratory Assistant | Reveal Email/Phone |
5 | Laboratory Assistant | Reveal Email/Phone |
6 | Sales Representative | Reveal Email/Phone |
7 | National Sales Manager | Reveal Email/Phone |
8 | Senior Research Associate | Reveal Email/Phone |
9 | QA | Reveal Email/Phone |
10 | Billing Clerk | Reveal Email/Phone |
IGeneX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.8M | 69 | 17% | N/A | N/A |
#2 | $177.5M | 526 | -1% | N/A | N/A |
#3 | $7.3M | 34 | 13% | N/A | N/A |
#4 | $12.9M | 55 | 28% | $25.9M | N/A |
#5 | $4.7M | 25 | -11% | N/A | N/A |
#6 | $14.8M | 61 | 20% | N/A | N/A |
#7 | $13.6M | 56 | 0% | N/A | N/A |
#8 | $5.3M | 28 | -7% | N/A | N/A |
#9 | $23.2M | 86 | 16% | N/A | N/A |
#10 | $13.9M | 57 | 2% | N/A | N/A |
What Is IGeneX?
For over 25 years, IGeneX has been at the forefront of Lyme disease and other tick-borne related illnesses. The company has not only made a profound impact on how these diseases get diagnosed more accurately with their testing diagnostics, it has also been instrumental in training physicians to better understand tick-borne diseases and become Lyme literate.
keywords:N/AN/A
Total Funding
61
Number of Employees
$14.8M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.5M | 61 | 1120% | N/A |
#2 | $5.8M | 64 | 5% | N/A |
#3 | $20.1M | 68 | 19% | N/A |
#4 | $17.3M | 71 | 16% | N/A |
#5 | $10.2M | 71 | 154% | N/A |